Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 5/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.50 |
| ▸ | HRH1 | P35367 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.49 |
| ▸ | GMNN | O75496 | 3/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.49 |
| ▸ | TP53 | P04637 | 3/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.49 |
| ▸ | BLM | P54132 | 2/20 | 0.49 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL94476 | 1.00 | LMNA (0.58) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL93717 | 1.00 | LMNA (0.58) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL27925466 | 0.93 | LMNA (0.66) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL27768779 | 0.93 | LMNA (0.66) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL27493791 | 0.92 | LMNA (0.64) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL27469410 | 0.89 | LMNA (0.60) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| Zinc Ion SCHEMBL7620932 | 0.87 | LMNA (0.58) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL27669980 | 0.87 | LMNA (0.58) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL2507637 | 0.87 | LMNA (0.58) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 | |
| SCHEMBL3899729 | 0.87 | LMNA (0.58) | LMNASMN1; SMN2MEN1KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2190402-B2 | BIOTIN AND SILICA IN DYE COMPOSITIONS | HENKEL AG & CO KGAA (DE) | 2018-10-17 | — | — | EP | claimed |
| EP-2190402-B1 | BIOTIN AND SILICA IN DYE COMPOSITIONS | HENKEL AG & CO KGAA (DE) | 2016-01-13 | — | — | EP | claimed |
| US-20140276480-A1 | BIOMOLECULAR WEARABLE APPARATUS | LIFEWAVE, INC. (US) | 2014-09-18 | — | — | US | claimed |
| US-8277516-B2 | Lightening agent having cationic acylpyridinium derivatives and certain ammonium compounds | HENKEL AG & CO. KGAA (DE) | 2012-10-02 | — | — | US | claimed |
| US-20120192890-A1 | LIGHTENING AGENT HAVING CATIONIC ACYLPYRIDINIUM DERIVATIVES AND CERTAIN AMMONIUM COMPOUNDS | HENKEL AG & CO. KGAA (DE) | 2012-08-02 | — | — | US | claimed |
| US-20110184356-A1 | BIOMOLECULAR WEARABLE APPARATUS | LIFEWAVE PRODUCTS, LLC (US) | 2011-07-28 | — | — | US | claimed |
| CN-1791615-A | A process for the preparation of hydroxy polymer esters and their use | CIBA SC HOLDING AG (CH) | 2006-06-21 | — | — | CN | claimed |
| US-9943672-B2 | Biomolecular wearable apparatus | LIFEWAVE, INC. (US) | 2018-04-17 | — | — | US | disclosed |
| US-9724531-B2 | Double helix conductor with light emitting fluids for producing photobiomodulation effects in living organisms | MEDICAL ENERGETICS LTD. (IE) | 2017-08-08 | — | — | US | disclosed |
| US-20140276480-A1 | BIOMOLECULAR WEARABLE APPARATUS | LIFEWAVE, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-8734316-B2 | Biomolecular wearable apparatus | LIFEWAVE, INC. (US) | 2014-05-27 | — | — | US | disclosed |
| US-8277516-B2 | Lightening agent having cationic acylpyridinium derivatives and certain ammonium compounds | HENKEL AG & CO. KGAA (DE) | 2012-10-02 | — | — | US | disclosed |
| US-20120192890-A1 | LIGHTENING AGENT HAVING CATIONIC ACYLPYRIDINIUM DERIVATIVES AND CERTAIN AMMONIUM COMPOUNDS | HENKEL AG & CO. KGAA (DE) | 2012-08-02 | — | — | US | disclosed |
| US-20110184356-A1 | BIOMOLECULAR WEARABLE APPARATUS | LIFEWAVE PRODUCTS, LLC (US) | 2011-07-28 | — | — | US | disclosed |
| CN-1791615-A | A process for the preparation of hydroxy polymer esters and their use | CIBA SC HOLDING AG (CH) | 2006-06-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120192890-A1 | LIGHTENING AGENT HAVING CATIONIC ACYLPYRIDINIUM DERIVATIVES AND CERTAIN AMMONIUM COMPOUNDS | KRT18, AAAS, KATNAL2 | LMNA 1111/4885SMN1; SMN2 4438/4885MEN1 4523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.